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A commentary on 
The C9orf72 repeat expansion disrupts nucleocytoplasmic transport 
by Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, et al. Nature (2015) 
525(7567):56–61. doi: 10.1038/nature14973
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that affects the upper and 
lower motor neurons. It has a focal onset but gradually spreads, leading to disability and, eventually, 
death. About 5–10% of ALS is inherited, usually following a dominant pattern. Pathological analysis 
revealed that motor neuron degeneration and death in the familial and sporadic forms is closely 
connected to protein aggregation and deposition, abnormal level and function of RNA molecules, 
abnormal neuronal cytoarchitecture, and non-neuronal cell death (1).
The GGGGCC hexanucleotide expansion (G4C2 HRE) in chromosome 9 open reading frame 72 
(C9orf72) gene is found in 40% of the familial ALS cases. It is also found in other neurodegenerative 
disorders, including frontotemporal dementias (FTDs) (2) and atypical parkinsonian syndromes (3).
The molecular mechanisms of C9orf72 ALS neurodegeneration are currently a subject of 
controversy. Two main pathophysiological models have been hypothesized with experimental 
evidence supporting both (4). The first is transcription of the HRE segments of the abnormal 
gene into abnormal RNA strands, which assemble into G-quadruplex structures, which directly 
interact with proteins and alter their function. The second is translation of this abnormal RNA into 
dipeptide repeat proteins (DPRs), which in turn can adversely influence cell function. Both of the 
above described mechanisms have the potential to influence the nuclear pore function by altering 
its protein complexes.
Zhang et al. have recently investigated the complex mechanisms that lead to impairment of the 
normal trafficking through the nuclear pore complex (NPC) associated with G4C2 HRE (5). They 
demonstrated that overexpression of RanGAP gene (which encodes a NPC protein – RanGAP1) 
rescued certain phenotypic traits associated with G4C2 HRE-mediated neurodegeneration by using 
(G4C2)30 Drosophila models. Different phenotypes were obtained by expressing the abnormal gene 
at different stages of fly development. If expressed in 1-day-old flies, the HRE sequence caused pro-
gressive defects in the photoreceptor organization, suggesting age-dependent neurodegeneration. 
Locomotor defects were noted in 15-day-old (G4C2)30 flies pointing toward motor neuron pathology. 
Both of these phenotypes were rescued either by RanGAP overexpression or by using a heterozygous 
RanGAP gain-of-function mutation. Conversely, photoreceptor degeneration was accelerated by 
RanGAP knockdown using RNA interference. When the (G4C2)30 HRE was expressed in larval 
motor neurons, it caused severe neuromuscular junction defects that were not rescued by RanGAP 
overexpression. These results suggested that RanGAP overactivity suppressed HRE-mediated neu-
rodegeneration in adult Drosophila, but HRE-mediated neurotoxicity in the larval stage is RanGAP 
independent.
2Munteanu and Lynch Nuclear Pore: Key to C9orf72-ALS?
Frontiers in Neurology | www.frontiersin.org March 2016 | Volume 7 | Article 51
The authors also studied the RanGAP/G4C2 RNA interaction 
in induced pluripotent stem cell (iPSC) neurons, derived from 
multiple C9orf72 ALS patients and noted that RanGAP G4C2 
RNA can colocalize in these cells. This interaction seems to lead 
to RanGAP loss-of-function, which was shown by a disrupted 
Ran nucleocytoplasmic gradient in cells expressing G4C2 HRE. 
HRE toxicity also appeared to be modulated by nucleocytoplas-
mic transport, and the data suggested that genetically enhancing 
nuclear import and/or inhibiting nuclear export can suppress 
G4C2-repeat-mediated degeneration in both Drosophila and 
human cells.
In order to prove that abnormal G4C2 HRE RNA is involved 
in the neurodegenerative pathophysiological pathway, the 
investigators treated C9 ALS iPSC neurons with antisense 
oligonucleotides targeting these molecules. The treatment 
rescued the disrupted Ran gradient, suggesting that the 
abnormal RNA may be responsible for the nucleocytoplasmic 
transport deficits. Neurodegenerative phenotype suppression 
also occurred using a nuclear export inhibitor, suggesting 
that nuclear export inhibition may compensate for disrupted 
nuclear import.
In summary, G4C2 HRE disrupts nucleocytoplasmic transport 
in Drosophila models and in human cells. RanGAP seems to be a 
key link in the pathophysiological chain, but other nuclear pore 
proteins may also be involved. Nuclear pore transport was previ-
ously implicated in both ALS and FTD pathophysiology, and data 
from this study suggest that the RNA fragments cause nucleo-
cytoplasmic trafficking defects by direct interaction with NPC 
proteins. However, other authors argued that DPRs can cause a 
reversible dysfunction of the NPC in the absence of abnormal 
C9orf72 RNA (4). These mechanisms can be complementary, and 
further work is needed to elucidate a potential link between them. 
The results presented suggest that nuclear pore dysfunction is key 
to neurodegeneration in C9orf72 ALS. The abnormal phenotype 
is reversible by modifying the RanGAP gene, suggesting a poten-
tial therapeutic approach.
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